Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy. [electronic resource]
Producer: 20150310Description: 12255-63 p. digitalISSN:- 1423-0380
- Adult
- Aged
- Aged, 80 and over
- Anthracyclines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Female
- Gene Expression
- Humans
- Immunohistochemistry
- Middle Aged
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Staging
- Prognosis
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Treatment Outcome
- Triple Negative Breast Neoplasms -- drug therapy
- Tumor Burden
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.